Results 121 to 130 of about 12,575 (207)

Dosing of ritonavir-boosted darunavir for treatment of HIV in pregnancy. [PDF]

AIDS
Sconza R, Taylor GP, Ene L, Kahlert C, van der Wekken-Pas L, Renaud F, Thorne C, Townsend CL, Epidemiology of Pregnancy and Paediatric Infections International Cohort Collaboration (EPPICC)* and London HIV Perinatal Research Group (LHPRG)*.   +8 more
europepmc   +1 more source

Reversible Effects of Integrase Inhibitors on Newly Differentiated Adipocytes. [PDF]

Viruses
Pickering RT, Asundi A, Olson A, Soden K, Lin NH.   +4 more
europepmc   +1 more source

Exploring the impact of baseline and on-treatment variables on durability of responses to fostemsavir through weeks 96 and 192 in the phase 3 BRIGHTE study. [PDF]

HIV Med
Gartland M, Wang X, Liao Q, Li B, Du F, Krystal M, Tenorio AR, Pierce A, Castillo-Mancilla JR.   +8 more
europepmc   +1 more source

Advancements in development of novel class of HIV protease inhibitors. [PDF]

Ann Med
Gu WG, Yin GZ, Zhang YP.
europepmc   +1 more source

Cardiometabolic impact of dolutegravir as second-line therapy: secondary analysis of a randomized controlled trial. [PDF]

AIDS
Nyein PP, Donoghoe MW, Eriobu N, Uche B, Kaplan R, Carey D, Brown D, Kundro M, Dharan NJ, Hanson J, Petoumenos K, Matthews GV, the D EFT study group.   +12 more
europepmc   +1 more source

Darunavir/Cobicistat [PDF]

, 2020
openaire   +1 more source

Highly Potent Phosphinic HIV‑1 Protease Inhibitors: Synthesis, In Vitro Evaluation, and Docking Studies. [PDF]

ACS Omega
Hayat K, Qiu D, Wang Y, Imbenzi PS, Khan FI, Matziari M.   +5 more
europepmc   +1 more source

Evolution and forecasting of antiretroviral therapy utilisation in British Columbia: a population-level analysis of provincial drug treatment programme data, 2014-2024. [PDF]

BMJ Open
Lima VD, Mokhtari Jazi A, Montaner JSG.
europepmc   +1 more source

Contemporary antiretroviral pharmacology in the male genital tract: implications for HIV treatment and prevention. [PDF]

Antimicrob Agents Chemother
Neverette NC, Winfield J, Chaparro-Cáceres N, Ho KS, Dumond JB, Devanathan AS.   +5 more
europepmc   +1 more source

2025 US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Post-exposure Prophylaxis in Healthcare Settings. [PDF]

Infect Control Hosp Epidemiol
Kofman AD, Struble KA, Heneine W, Gayle B, de Perio MA, Okasako-Schmucker DL, So CN, Anderson LE, Stone EC, Henderson DK, Kuhar DT.   +10 more
europepmc   +1 more source